News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jim Palma: I have joined the Advisory Board of the TRACER at the Fred Hutch Cancer Center
Jim Palma/targetcancer.org
Mar 27, 2025, 18:35

Jim Palma: I have joined the Advisory Board of the TRACER at the Fred Hutch Cancer Center

Jim Palma, CEO at Target Cancer Foundation, shared a post on LinkedIn:

“I am happy to share that I have joined the Advisory Board of the TRACER-Transformative Rare Cancer Initiative at the Fred Hutch Cancer Center in Seattle.

It has been a pleasure over the past year to begin a partnership with TRACER Director Taran Gujral, and I’m looking forward to expanding this cross-country rare cancer collaboration in the years to come!”

More posts featuring Jim Palma.

cancer Fred Hutch Cancer Center Jim Palma OncoDaily Oncology Taran Gujral TRACER Transformative Rare Cancer Initiative
Special Coverage
Science
Jun 1, 2025, 15:26
BNT142-01 Trial at ASCO 2025 Demonstrates First-in-Human Activity of mRNA-Encoded Bispecific Antibody in CLDN6+ Solid Tumors
Career
Jun 1, 2025, 15:07
Mohammad Jad Moussa: A badge of honor to wrap up my postdoc at MD Anderson
Insight
Jun 1, 2025, 14:56
Debra Patt on the Importance of Policy Engagement in Oncology at ASCO 2025
Insight
Jun 1, 2025, 14:52
Key Insights by Tom Powles from ASCO25
Insight
Jun 1, 2025, 14:50
Pashtoon Kasi Highlighted Study on Vilastobart (XTX101) + Atezolizumab in MSS Colorectal Cancer at ASCO 2025
Science
Jun 1, 2025, 14:48
First results of SURE-02 Trial presented at ASCO 2025 by Andrea Necchi
Insight
Jun 1, 2025, 14:41
Aakash Desai: Interim Results from Our Phase 1 Trial of PDL1V, a Vedotin-Based ADC Targeting PD-L1 in R/R NSCLC at ASCO 2025
Blog
Jun 1, 2025, 14:39
Christina Ip-Toma: Integrating germline and tumor genetic results to reduce disparities in cancer care
Blog
Jun 1, 2025, 14:38
Key Insights by Petros Grivas from ASCO25
Science
Jun 1, 2025, 14:38
Kriti Mittal: The ASCO special edition of the ASPIRE CoP newsletter
Oncolibrary
Jun 1, 2025, 13:48
Romiplostim for Chemotherapy-induced Thrombocytopenia Results from global phase iii trial in Gi cancers
Opinion
Jun 1, 2025, 13:42
Efficacy of IL-6R Blockade with Sarilumab in a Quadruple Immuno-Oncology Regimen for Patients with Unresectable Stage III/IV Melanoma